Principal Investigators

As of September 1, 2009, the NHLBI has supported hundreds of principal investigators (PIs) with American Recovery and Reinvestment (the Recovery Act) funds, using existing mechanisms, such as expansion of the research paylines from 2008 and 2009, as well as new programs created specifically for the Recovery Act, including Challenge Grants, and Grand Opportunities (GO) grants. Learn more about the scientists who are directing projects or programs supported by grants.

Below are profiles of Recovery Act-funded scientists who provided their photographs to the NHLBI. To find out more about their projects or to see all the NHLBI-funded Recovery Act projects, use the search tool on the right. If you are a PI, please consider sharing your Recovery Act story and photograph for publication on these Web pages.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z     

Kenneth Melvin Baker, M.D. Professor, Texas A&M University Health Science Center, College Station, Texas Role of Retinoid Mediated Signaling in Diabetes and Cardiac Remodeling Administered by the NHLBI Division of Cardiovascular Sciences, Heart Failure and Arrhythmia Branch FY 2009 Recovery Act Funding: $393,750 More information about the grant Additional Funding: Role of Retinoid Mediated Signaling in Diabetes and Cardiac Remodeling Administered by the NHLBI Division of Cardiovascular Sciences, Heart Failure and Arrhythmia Branch FY 2010 Recovery Act Funding: $399,227 More information about the grant Total funding: $792,977

Agnieszka Balkowiec, M.D., Ph.D. Associate Professor, Department of Integrative Biosciences, Oregon Health and Science University School of Dentistry, Portland, Oregon Neutrophins and Development of Baroreceptor Pathways Administered by the NHLBI Division of Cardiovascular Sciences, Vascular Biology and Hypertension Branch FY 2009 Recovery Act Funding: $174,342 More information about the grant

Mike Bamshad, M.D. Professor of Pediatrics, University of Washington School of Medicine, Seattle, Washington ARRA - NHLBI Lung Cohorts Sequencing Project Administered by the NHLBI Division of Lung Diseases, Airway Biology and Disease Branch FY 2009 Recovery Act Funding: $2,594,102 More information about the grant Additional Funding: ARRA - NHLBI Lung Cohorts Sequencing Project Administered by the NHLBI Division of Lung Diseases, Airway Biology and Disease Branch FY 2010 Recovery Act Funding: $2,561,111 More information about the grant Total funding: $5,155,213

Utpal Banerjee, Ph.D. Iriving and Jean Stone Chair in Life Sciences, University of California Los Angeles, Los Angeles, California Student and/or teacher training opportunities Administered by the NHLBI Division of Blood Diseases and Resources, Transfusion Medicine and Cellular Therapeutics Branch FY 2009 Recovery Act Funding: $19,829 More information about the grant

R. Graham Barr, M.D., Dr.P.H. Florence Irving Assistant Professor of Medicine; Assistant Professor of Epidemiology, Columbia University Medical Center, New York, New York Genome-wide and Linkage Study of Quantitative Emphysema Phenotypes Administered by the NHLBI Division of Lung Diseases, Airway Biology and Disease Branch FY 2009 Recovery Act Funding: $499,863 More information about the grant Additional Funding: Genome-wide and Linkage Study of Quantitative Emphysema Phenotypes Administered by the NHLBI Division of Lung Diseases, Airway Biology and Disease Branch FY 2010 Recovery Act Funding: $470,593 More information about the grant Total funding: $970,456

Craig T. Basson, M.D., Ph.D. Gladys and Roland Harriman Professor of Medicine, Weill Medical College of Cornell University, New York, New York Let-7 miRNA Control of Heart Development Administered by the NHLBI Division of Cardiovascular Sciences, Atherothrombosis and Coronary Artery Disease Branch FY 2009 Recovery Act Funding: $499,998 More information about the grant

Sompop Bencharit, D.D.S., M.S., Ph.D. Assistant Professor, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina Role of Programmed Cell Death10 (PDCD10) in p38 MAP kinase activation and PDK1 si Administered by the the NHLBI Division of Cardiovascular Sciences, Vascular Biology and Hypertension Branch FY 2009 Recovery Act Funding: $185,000 More information about the grant

Emelia J. Benjamin, M.D., Sc.M. Professor of Medicine and Epidemiology, Boston University Schools of Medicine and Public Health, Boston, Massachusetts Risk Prediction of Atrial Fibrillation: Clinical, Biological, and Genetic Markers Administered by the NHLBI Division of Cardiovascular Sciences, Epidemiology Branch FY 2009 Recovery Act Funding: $492,694 More information about the grant Additional Funding: Risk Prediction of Atrial Fibrillation: Clinical, Biological, and Genetic Markers Administered by the NHLBI Division of Cardiovascular Sciences, Epidemiology Branch FY 2010 Recovery Act Funding: $474,529 More information about the grant Total funding: $967,223

Ivor J. Benjamin, M.D. Professor, University of Utah, Salt Lake City, Utah Reductive Stress in the Pathogenesis of R120GCryAB Cardiomyopathy Administered by the NHLBI Division of Cardiovascular Sciences, Heart Failure and Arrhythmia Branch FY 2009 Recovery Act Funding: $433,005 More information about the grant Additional Funding: Reductive Stress in the Pathogenesis of R120GCryAB Cardiomyopathy Administered by the NHLBI Division of Cardiovascular Sciences, Heart Failure and Arrhythmia Branch FY 2010 Recovery Act Funding: $441,466 More information about the grant Total funding: $874,471

Nanette H. Bishopric, M.D. Professor, University of Miami School of Medicine, Miami, Coral Gables, Florida Transcription Programming in Cardiac Growth Administered by the NHLBI Division of Cardiovascular Sciences, Heart Failure and Arrhythmia Branch FY 2009 Recovery Act Funding: $23,984 More information about the grant

J. Edwin Blalock, Ph.D. Professor, University of Alabama at Birmingham, Birmingham, Alabama Therapeutics for Chronic Lung Diseases: Antagonists of PGP, Chemokines and CXCR Administered by the NHLBI Division of Lung Diseases, Lung Biology and Disease Branch FY 2009 Recovery Act Funding: $411,364 More information about the grant Additional Funding: Effect of Macrolide Treatment on a Novel Pathway of Neutrophilic Inflammation Administered by the NHLBI Division of Lung Diseases, Lung Biology and Disease Branch FY 2009 Recovery Act Funding: $42,413 More information about the grant Therapeutics for Chronic Lung Diseases: Antagonists of PGP, Chemokines and CXCR Administered by the NHLBI Division of Lung Diseases, Lung Biology and Disease Branch FY 2010 Recovery Act Funding: $411,690 More information about the grant Total funding: $865,467

Eric Boerwinkle, Ph.D. Director, Human Genetics Center, School of Public Health, University of Texas Health Science Center, Houston, Texas Building on GWAS for NHLBI Diseases: The CHARGE Consortium Administered by the NHLBI Division of Cardiovascular Sciences, Epidemiology Branch FY 2009 Recovery Act Funding: $12,281,613 More information about the grant

Gary M. Bokoch, Ph.D. Professor, Scripps Research Institute, La Jolla, California G Protein Regulation of the Neutrophil NADPH Oxidase Administered by the NHLBI Division of Cardiovascular Sciences, Vascular Biology and Hypertension Branch FY 2009 Recovery Act Funding: $710,981 More information about the grant

Julie Buring, Sc.D., M.S. Professor, Department of Epidemiology, Brigham and Women's Hospital, Boston, Massachusetts The Women's Health Study: Addition of New Data to Maximize its Research Impact Administered by the NHLBI Division of Cardiovascular Sciences, Atherothrombosis and Coronary Artery Disease Branch FY 2009 Recovery Act Funding: $499,778 More information about the grant Additional Funding: The Women's Health Study: Addition of New Data to Maximize its Research Impact Administered by the NHLBI Division of Cardiovascular Sciences, Atherothrombosis and Coronary Artery Disease Branch FY 2010 Recovery Act Funding: $492,524 More information about the grant Total funding: $992,302

Michael Busch, M.D., Ph.D. Vice President, Research and Scientific Affairs, Blood Systems Research Institute, San Francisco, California Viral/Immune Parameters of Dengue and WNV in Donors: Blood Safety Implications Administered by the NHLBI Division of Blood Diseases and Resources, Transfusion Medicine and Cellular Therapeutics Branch FY 2009 Recovery Act Funding: $1,051,726 More information about the grant

Last Updated: March 16, 2010